+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oxymorphone"

From
From
Oxymorphone (CAS 76-41-5) Global Market Research Report 2024 - Product Thumbnail Image

Oxymorphone (CAS 76-41-5) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

  • Report
  • November 2021
  • 600 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Oxymorphone is an opioid analgesic drug used to treat moderate to severe pain. It is a semi-synthetic opioid derived from thebaine, an alkaloid found in the opium poppy. Oxymorphone is available in both immediate-release and extended-release formulations. The immediate-release formulation is used for the relief of acute pain, while the extended-release formulation is used for the management of chronic pain. Oxymorphone is typically prescribed for patients who have not responded to other analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen. Oxymorphone is a controlled substance in many countries, and its use is subject to strict regulations. It is important to note that oxymorphone is highly addictive and can lead to physical and psychological dependence. Companies in the oxymorphone market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more